The Promising Future for Complex Innovative Trial Design in Clinical Research

Authors

  • Brijesh Sathian Deputy Chair for Research, Geriatrics and Long Term Care Department, Rumailah Hospital, Doha, Qatar
  • Edwin van Teijlingen Centre for Midwifery, Maternal and Perinatal Health, Bournemouth University, Bournemouth, UK https://orcid.org/0000-0001-5523-8583
  • Indrajit Banerjee Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Mauritius
  • Mohammad Asim Clinical Research, Trauma and Vascular Surgery, Surgery Department, Hamad General Hospital, Doha, Qatar
  • Russell Kabir School of Allied Health, Anglia Ruskin University, Essex, UK

DOI:

https://doi.org/10.3126/nje.v13i1.53722

Keywords:

Complex Innovative Trial Design, randomized controlled trial, Clinical Trial

Abstract

Complex Innovative Trial Design (CID) offers several potential benefits for clinical research, including the use of novel statistical techniques such as adaptive designs and Bayesian methods that require computer simulation to determine operating characteristics. By leveraging these techniques, CID has the potential to increase the probability of success for clinical trials while simultaneously reducing the time and cost required for drug development.

Downloads

Download data is not yet available.
Abstract
175
PDF
180

Author Biography

Brijesh Sathian, Deputy Chair for Research, Geriatrics and Long Term Care Department, Rumailah Hospital, Doha, Qatar

and Centre for Midwifery, Maternal and Perinatal Health, Bournemouth University, Bournemouth, UK

Downloads

Published

2023-03-31

How to Cite

Sathian, B., van Teijlingen, E., Banerjee, I. ., Asim, M., & Kabir, R. (2023). The Promising Future for Complex Innovative Trial Design in Clinical Research. Nepal Journal of Epidemiology, 13(1), 1256–1257. https://doi.org/10.3126/nje.v13i1.53722

Issue

Vol. 13 No. 1 (2023)

Section

Editorial

License

Copyright (c) 2023 CEA & INEA

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  • Upon acceptance Copyright on any research article is transferred in full to the Confederation of Epidemiological Associations (CEA) and International Nepal Epidemiological Association (INEA).  The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
  • Articles in the Nepal Journal of Epidemiology are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
  • This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.